Cargando…
Validation of an algorithm able to differentiate small-cell lung cancer (SCLC) from non-small-cell lung cancer (NSCLC) patients by means of a tumour marker panel: analysis of the errors.
By means of a mathematical score previously generated by discriminant analysis on 90 lung cancer patients, a new and larger group of 261 subjects [209 with non-small-cell lung cancer (NSCLC) and 52 with small-cell lung cancer (SCLC)] was analysed to confirm the ability of the method to distinguish b...
Autores principales: | Paone, G., De Angelis, G., Portalone, L., Greco, S., Giosué, S., Taglienti, A., Bisetti, A., Ameglio, F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063371/ https://www.ncbi.nlm.nih.gov/pubmed/9020496 |
Ejemplares similares
-
Is transformed small cell lung cancer (SCLC) different from de novo SCLC?
por: Park, Cheol-Kyu, et al.
Publicado: (2019) -
Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC)
por: Saltos, Andreas, et al.
Publicado: (2020) -
Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
por: Jørgensen, L. G., et al.
Publicado: (1994) -
An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker
por: Wei, Kanglai, et al.
Publicado: (2016) -
Small Cell Lung Cancer (SCLC) Presenting as Acute Pancreatitis: The Role of Hypercalcemia
por: Tan, Jessica, et al.
Publicado: (2012)